Wanqiu Chen

Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice.

Melatonin decreases mortality following severe subarachnoid hemorrhage.

HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.

Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase.

Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury.

Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats.

HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury.

Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain.

Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen.

Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats.

Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice.

Maternal hypoxia increases the activity of MMPs and decreases the expression of TIMPs in the brain of neonatal rats.

Role of gap junctions in early brain injury following subarachnoid hemorrhage.

Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.

Ac-YVAD-CMK Decreases Blood-Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1β in Intracerebral Hemorrhage Mouse Model.

Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.

Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage.

Role of osteopontin in early brain injury after subarachnoid hemorrhage in rats.

Mechanisms of statin treatment in cerebral vasospasm.

Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Arteriovenous malformation in the adult mouse brain resembling the human disease.

Subarachnoid hemorrhage causes pulmonary endothelial cell apoptosis and neurogenic pulmonary edema in mice.

Endothelin receptor-A (ETa) inhibition fails to improve neonatal hypoxic-ischemic brain injury in rats.

Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats.

Pretreatment with normobaric and hyperbaric oxygenation worsens cerebral edema and neurologic outcomes in a murine model of surgically induced brain injury.

Granulocyte colony-stimulating factor treatment provides neuroprotection in surgically induced brain injured mice.

Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

Hydrogen is neuroprotective against surgically induced brain injury.

Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.

Induction of brain arteriovenous malformation in the adult mouse.

Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.

Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Generation of Mesenchymal Stem Cells by Blood Cell Reprogramming.

PDGFB-based stem cell gene therapy increases bone strength in the mouse.

Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency.